Galderma (SIX: GALD), the pure-play dermatology category leader, has announced the launch of Restylane Defyne and Restylane Refyne: the first OBT‑based hyaluronic acid injectables ever authorized in ...

Millions of Americans have had their lips plumped and wrinkles smoothed with injectable fillers. But many complain facial expressions don't always look natural. Now two new entries in the filler ...

Results showed that 74% of Restylane Defyne-treated patients achieved significantly improved chin projection for up to 1 year. The Food and Drug Administration (FDA) has approved Restylane ® Defyne ...

Galderma, the pure-play dermatology category leader, has announced the launch of Restylane Defyne and Restylane Refyne: the first OBT-based hyaluronic acid injectables ever authorized in Japan. The ...

Restylane Refyne and Restylane Defyne are the first Optimal Balance Technology (OBT) hyaluronic acid injectables ever approved and launched in Japan, bringing advanced flexibility and natural movement ...